Bhatia Sangeeta N. 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Oct 19, 2023
Insider Transaction Report
Form 4
Bhatia Sangeeta N.
Director
Transactions
- Sale
Common Stock
2023-10-17$375.00/sh−243$91,125→ 3,901 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/10/2023.